The share of Medicare Part D claims eligible for discounts in the 340B drug pricing program increased from 1.7 percent to 9.6 percent between 2013 and 2020, a study published in JAMA Health Forum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results